Roxbury Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Buy
452
+2
+0.4% +$742 0.14% 109
2026
Q1
$132K Buy
450
+2
+0.4% +$657 0.12% 117
2025
Q4
$157K Buy
448
+1
+0.2% +$338 0.14% 105
2025
Q3
$144K Buy
447
+2
+0.4% +$622 0.13% 112
2025
Q2
$173K Sell
445
-17
-4% -$6.84K 0.17% 96
2025
Q1
$183K Sell
462
-4
-0.9% -$1.61K 0.18% 90
2024
Q4
$190K Buy
+466
New +$195K 0.18% 91

Other funds holding ELV

Roxbury Financial's ELV Position: Q2 2026 in Review

Roxbury Financial increased its Elevance Health (ELV) stake by 0.44% in Q2 2026, buying an estimated $742 and bringing the position to 452 shares worth $175K. The position accounts for 0.14% of the portfolio, ranked #109.

Roxbury Financial first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $190K in Q4 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Roxbury Financial held 452 shares of Elevance Health worth $175K as of Q2 2026.
  • Roxbury Financial bought 2 Elevance Health shares in Q2 2026, an estimated $742.
  • Elevance Health made up 0.14% of Roxbury Financial's portfolio in Q2 2026, its #109 holding.
  • Roxbury Financial first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Roxbury Financial's Elevance Health position peaked at $190K in Q4 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.